| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4577125
Max Phase: Preclinical
Molecular Formula: C23H23ClN2O5S
Molecular Weight: 474.97
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CC(C)(O)c1ccccc1Oc1ccc(NC(=O)Cc2ccccc2Cl)cc1S(N)(=O)=O
Standard InChI: InChI=1S/C23H23ClN2O5S/c1-23(2,28)17-8-4-6-10-19(17)31-20-12-11-16(14-21(20)32(25,29)30)26-22(27)13-15-7-3-5-9-18(15)24/h3-12,14,28H,13H2,1-2H3,(H,26,27)(H2,25,29,30)
Standard InChI Key: XUYWLNASVXFIEG-UHFFFAOYSA-N
Associated Targets(Human)
P2X purinoceptor 4 516 Activities
Pregnane X receptor 6667 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 474.97 | Molecular Weight (Monoisotopic): 474.1016 | AlogP: 4.19 | #Rotatable Bonds: 7 |
| Polar Surface Area: 118.72 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.39 | CX Basic pKa: | CX LogP: 3.69 | CX LogD: 3.68 |
| Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.47 | Np Likeness Score: -1.36 |
References
| 1. Werner S, Mesch S, Hillig RC, Ter Laak A, Klint J, Neagoe I, Laux-Biehlmann A, Dahllöf H, Bräuer N, Puetter V, Nubbemeyer R, Schulz S, Bairlein M, Zollner TM, Steinmeyer A.. (2019) Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile., 62 (24): [PMID:31746599] [10.1021/acs.jmedchem.9b01304] |
Source
Source(1):